国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Macrococcus caseolyticus Elongation factor P (efp) CSB-YP495226MPA
CSB-EP495226MPA
CSB-BP495226MPA
CSB-MP495226MPA
CSB-EP495226MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Probable rRNA maturation factor (MCCL_1222) CSB-YP495227MPA
CSB-EP495227MPA
CSB-BP495227MPA
CSB-MP495227MPA
CSB-EP495227MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Shikimate dehydrogenase (aroE) CSB-YP495228MPA
CSB-EP495228MPA
CSB-BP495228MPA
CSB-MP495228MPA
CSB-EP495228MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP495229MPA
CSB-EP495229MPA
CSB-BP495229MPA
CSB-MP495229MPA
CSB-EP495229MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Trigger factor (tig) CSB-YP495230MPA
CSB-EP495230MPA
CSB-BP495230MPA
CSB-MP495230MPA
CSB-EP495230MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Probable tRNA sulfurtransferase (thiI) CSB-YP495231MPA
CSB-EP495231MPA
CSB-BP495231MPA
CSB-MP495231MPA
CSB-EP495231MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP495232MPA
CSB-EP495232MPA
CSB-BP495232MPA
CSB-MP495232MPA
CSB-EP495232MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 10 kDa chaperonin (groS) CSB-YP495233MPA
CSB-EP495233MPA
CSB-BP495233MPA
CSB-MP495233MPA
CSB-EP495233MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus ATP synthase gamma chain (atpG) CSB-YP495234MPA
CSB-EP495234MPA
CSB-BP495234MPA
CSB-MP495234MPA
CSB-EP495234MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 50S ribosomal protein L31 type B (rpmE2) CSB-YP495235MPA
CSB-EP495235MPA
CSB-BP495235MPA
CSB-MP495235MPA
CSB-EP495235MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP495236MPA
CSB-EP495236MPA
CSB-BP495236MPA
CSB-MP495236MPA
CSB-EP495236MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus DNA replication and repair protein recF (recF) CSB-YP495237MPA
CSB-EP495237MPA
CSB-BP495237MPA
CSB-MP495237MPA
CSB-EP495237MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Lactate utilization protein A (lutA) CSB-YP495238MPA
CSB-EP495238MPA
CSB-BP495238MPA
CSB-MP495238MPA
CSB-EP495238MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 30S ribosomal protein S19 (rpsS) CSB-YP495239MPA
CSB-EP495239MPA
CSB-BP495239MPA
CSB-MP495239MPA
CSB-EP495239MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 30S ribosomal protein S8 (rpsH) CSB-YP495240MPA
CSB-EP495240MPA
CSB-BP495240MPA
CSB-MP495240MPA
CSB-EP495240MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus 50S ribosomal protein L17 (rplQ) CSB-YP495241MPA
CSB-EP495241MPA
CSB-BP495241MPA
CSB-MP495241MPA
CSB-EP495241MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP495242MPA
CSB-EP495242MPA
CSB-BP495242MPA
CSB-MP495242MPA
CSB-EP495242MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus UPF0042 nucleotide-binding protein MCCL_0516 (MCCL_0516) CSB-YP495243MPA
CSB-EP495243MPA
CSB-BP495243MPA
CSB-MP495243MPA
CSB-EP495243MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Adapter protein mecA (mecA) CSB-YP495244MPA
CSB-EP495244MPA
CSB-BP495244MPA
CSB-MP495244MPA
CSB-EP495244MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrococcus caseolyticus Heme A synthase (ctaA), partial CSB-YP495245MPA
CSB-EP495245MPA
CSB-BP495245MPA
CSB-MP495245MPA
CSB-EP495245MPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>